Fred Alger Management’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $62.5M | Sell |
416,566
-205,693
| -33% | -$22.4M | 0.21% | 61 |
|
|
2026
Q1 | $57.5M | Buy |
622,259
+32,603
| +6% | +$3.27M | 0.25% | 50 |
|
|
2025
Q4 | $60.2M | Sell |
589,656
-48,831
| -8% | -$4.37M | 0.24% | 57 |
|
|
2025
Q3 | $39.9M | Buy |
638,487
+264,808
| +71% | +$14.4M | 0.16% | 74 |
|
|
2025
Q2 | $19.4M | Sell |
373,679
-83,938
| -18% | -$3.75M | 0.09% | 120 |
|
|
2025
Q1 | $19.5M | Buy |
457,617
+302,145
| +194% | +$13M | 0.11% | 111 |
|
|
2024
Q4 | $4.75M | Buy |
155,472
+43
| +0% | +$1.21K | 0.02% | 248 |
|
|
2024
Q3 | $3.57M | Sell |
155,429
-43,039
| -22% | -$1.22M | 0.02% | 279 |
|
|
2024
Q2 | $5.73M | Buy |
198,468
+64,206
| +48% | +$1.5M | 0.03% | 234 |
|
|
2024
Q1 | $2.77M | Buy |
134,262
+82,946
| +162% | +$1.78M | 0.01% | 315 |
|
|
2023
Q4 | $1.39M | Sell |
51,316
-508
| -1% | -$13.3K | 0.01% | 353 |
|
|
2023
Q3 | $1.54M | Buy |
+51,824
| New | +$1.82M | 0.01% | 341 |
|
|
2023
Q2 | – | Sell |
-10,000
| Closed | -$234K | – | 540 |
|
|
2023
Q1 | $234K | Sell |
10,000
-478
| -5% | -$13.7K | ﹤0.01% | 422 |
|
|
2022
Q4 | $285K | Sell |
10,478
-103,268
| -91% | -$4.73M | ﹤0.01% | 426 |
|
|
2022
Q3 | $6.12M | Sell |
113,746
-3,051
| -3% | -$157K | 0.03% | 241 |
|
|
2022
Q2 | $4.71M | Sell |
116,797
-252,878
| -68% | -$12.5M | 0.02% | 268 |
|
|
2022
Q1 | $24.5M | Sell |
369,675
-1,380,516
| -79% | -$94.5M | 0.08% | 177 |
|
|
2021
Q4 | $175M | Sell |
1,750,191
-913,431
| -34% | -$94.5M | 0.44% | 71 |
|
|
2021
Q3 | $333M | Sell |
2,663,622
-141,172
| -5% | -$16.8M | 0.79% | 31 |
|
|
2021
Q2 | $348M | Buy |
2,804,794
+167,305
| +6% | +$22.5M | 0.82% | 25 |
|
|
2021
Q1 | $403M | Buy |
2,637,489
+567,042
| +27% | +$85.7M | 1.05% | 14 |
|
|
2020
Q4 | $267M | Buy |
2,070,447
+126,880
| +7% | +$14.6M | 0.69% | 36 |
|
|
2020
Q3 | $217M | Sell |
1,943,567
-147,548
| -7% | -$13.5M | 0.63% | 38 |
|
|
2020
Q2 | $170M | Buy |
2,091,115
+892,602
| +74% | +$71.9M | 0.56% | 42 |
|
|
2020
Q1 | $83.4M | Sell |
1,198,513
-136,247
| -10% | -$10.5M | 0.37% | 66 |
|
|
2019
Q4 | $104M | Buy |
1,334,760
+1,077,513
| +419% | +$77.7M | 0.38% | 70 |
|
|
2019
Q3 | $16.4M | Sell |
257,247
-41,062
| -14% | -$3.62M | 0.06% | 170 |
|
|
2019
Q2 | $25.8M | Buy |
298,309
+195,148
| +189% | +$14.9M | 0.1% | 151 |
|
|
2019
Q1 | $7.91M | Buy |
103,161
+34,032
| +49% | +$1.89M | 0.03% | 191 |
|
|
2018
Q4 | $2.6M | Buy |
+69,129
| New | +$2.55M | 0.01% | 263 |
|
Other funds holding GH
DTC
Fred Alger Management's GH Position: Q2 2026 in Review
Fred Alger Management reduced its Guardant Health (GH) stake by 33% in Q2 2026, selling an estimated $22.4M and leaving 416,566 shares worth $62.5M. The position accounts for 0.21% of the portfolio, ranked #61.
Fred Alger Management first reported a position in GH in Q4 2018 and has held it in 30 quarters since. The position peaked at $403M in Q1 2021. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- Fred Alger Management held 416,566 shares of Guardant Health worth $62.5M as of Q2 2026.
- Fred Alger Management sold 205,693 Guardant Health shares in Q2 2026, an estimated $22.4M.
- Guardant Health made up 0.21% of Fred Alger Management's portfolio in Q2 2026, its #61 holding.
- Fred Alger Management first reported a position in Guardant Health in Q4 2018 and has held it in 30 quarters since.
- Fred Alger Management's Guardant Health position peaked at $403M in Q1 2021.
- 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on Fred Alger Management's 13F filing for Q2 2026, filed 14 Aug 2026.